Insightful analysis and commentary for the US and global equity investor
Contributors: Douglas McIntyre Jon C. Ogg

Previous Posts

Monday, October 09, 2006

Cramer's MAD MONEY (Oct. 9, 2006):

Today on Jim Cramer's STOP TRADING segment on CNBC Cramer reviewed his favorite telecom and biotech stock.

On telecom Cramer AT&T (T) as the clear core holding in the group. He thinks the SBC unit is ahead of Verizon and he thinks AT&T is the best in the group. He said they will be able to cut costs more. He said there may even be video shortages and he said he thought Qwest (Q) should have done a dividend.

he did not that someone would buy Sprint (S) because they have too big of a footprint.

In pharma, Cramer said GlaxoSmithkline (GSK) is the best one out there and they are not US-based. He said GSK is a share taker on shelf space and they are best of breed. He said GSK does not seem as defensive as other companies have had to be and they are more positive and not as afraid of the media compared to others.

Cramer did say Bristol-Myers (BMY) should be for sale, but noted first that they are in the dog house.

Jon C. Ogg
 Subscribe

Powered by Blogger